Home FDA labels bb001c15-9f5c-454e-b12d-e8664b16f80b FDA label bb001c15-9f5c-454e-b12d-e8664b16f80b openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID c095ffa5-3786-44ef-9a66-e8441e39dee1
SPL ID bb001c15-9f5c-454e-b12d-e8664b16f80b
Version 1
Effective date 2010-09-08
Source export date 2026-09-28
Source partition 6
Source file https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
Source manifest SHA-256 cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run 20260929T050834Z
Imported at 2026-09-29 05:39:44 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infection Folliculitis Skin atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation
adverse reactions table <table ID="ic497d6b3-9ac8-4395-86f7-2210b45950a7"> <col align="left" width="1"/> <col align="left" width="1"/> <tbody> <tr> <td>Burning</td> <td>Perioral dermatitis</td> </tr> <tr> <td>Itching</td> <td>Allergic contact dermatitis</td> </tr> <tr> <td>Irritation</td> <td>Maceration of the skin</td> </tr> <tr> <td>Dryness</td> <td>Secondary infection</td> </tr> <tr> <td>Folliculitis</td> <td>Skin atrophy</td> </tr> <tr> <td>Hypertrichosis</td> <td>Striae</td> </tr> <tr> <td>Acneiform eruptions</td> <td>Miliaria</td> </tr> <tr> <td>Hypopigmentation</td> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.